# Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

> **NCT00131872** · PHASE2 · TERMINATED · sponsor: **LeMaitre Vascular** · enrollment: 172 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Expedial Vascular Access Graft

## Key facts

- **NCT ID:** NCT00131872
- **Lead sponsor:** LeMaitre Vascular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131872, "Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00131872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*